EFFPAC: Novel Paclitaxel DCB for PAD Demonstrates Efficacy With No Mortality Signal - TCTMD
EFFPAC: Novel Paclitaxel DCB for PAD Demonstrates Efficacy With No Mortality Signal TCTMD
PARIS, France—Compared with plain balloon angioplasty (POBA), a paclitaxel-coated balloon results in better patency and less TLR at 24 months in ...
Comments
Post a Comment